Cardinal Health, Inc.
CAH · NYSE
- $234.57
- $54.63B
- Open
- —
- —
- $232.60 - $237.57
- $145.87 - $258.30
- —
- —
- 2.17M
About Cardinal Health, Inc.
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and provides medical products and related supply-chain services. Its Pharmaceutical and Specialty Solutions business is the larger revenue engine, serving pharmacies, hospitals, healthcare providers, and pharmaceutical manufacturers; its medical-products business serves hospitals, ambulatory facilities, laboratories, and other providers. The company earns revenue primarily through product distribution and related services. Cardinal operates at substantial scale: fiscal 2025 revenue is $222.6 billion and net income is $1.6 billion, compared with $226.8 billion of revenue and $0.9 billion of net income in fiscal 2024.
Notable Price Movement
- Aug 3-7$236.402.77%
Cardinal Health rose $1.04, or 0.45%, over the week, from $232.51 to $233.55. The move was concentrated on Monday, when shares gained 2.42% to $235.60 after Zacks highlighted the stock’s outperformance and ahead-of-report earnings expectations. Shares then gave back $2.05, or 0.87%, on Tuesday, leaving only a modest net advance. Zacks also described Cardinal as a strong value stock, but the supplied evidence identifies no earnings release, guidance change, contract, or other company-specific event during the period. The stock therefore moved higher amid pre-earnings positioning and favorable value commentary, with the reversal indicating limited follow-through rather than a sustained breakout.
Stories & Analysis
